NYSE American · Packaged Foods · USD
SRX Global Inc. (SRXH) Stock Analysis
SRX Global Inc. (SRXH) is a Packaged Foods stock listed on NYSE American and quoted in US Dollar.
Last Updated: October 21, 2026
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
SRXH Key Statistics
As of Oct 21, 2026Trading
- Open
- $1.14
- Previous Close
- $1.14
- Day's Range
- 1.10–1.15
- 52-Week Range
- 0.96–42.60
- Volume
- 355.15K
Valuation
- Market Cap
- $22.20M
Financials (FY)
- Revenue (FY)
- $6.53M
- Net Income (FY)
- −$45.01M
- Shares Outstanding
- 20.18M
- 1-Year Return
- −94.32%
Dividend and dates
- Ex-Dividend Date
- July 22, 2026
- Avg Volume
- 870.66K
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
Key facts
As of October 21, 2026, SRXH closed at $1.10, −94.32% over 1 year.
SRX Global Inc. (SRXH) has a market capitalization of $22.20M.
In fiscal 2025, SRXH reported revenue of $6.53M.
SRXH Stock Return by Calendar Year
SRX Global Inc. (SRXH) 10-year return: what $10,000 became
- 1 year
- $10,000 $568
- −94.32%
- 5 years
- $10,000 $2
- −99.98%
- 10 years
- $10,000 $0.02
- −99.9998%
If you had invested $10,000 in SRX Global Inc. (SRXH) 10 years ago, at the close on October 21, 2016, it would have been worth $0.02 at the close on October 21, 2026: −99.9998% in total, −72.87% a year, with dividends reinvested. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | −91.75% |
| 2025 | −86.90% |
| 2024 | −78.79% |
| 2023 | −48.61% |
| 2022 | −83.31% |
| 2021 | −57.61% |
| 2020 | −52.96% |
| 2019 | −75.85% |
| 2018 | −18.10% |
| 2017 | −73.35% |
| 2016 (partial year) | +4.79% |
As of October 21, 2026.
SRXH Revenue and Earnings by Fiscal Year
FY ends September| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $6.53M | −$45.01M | −688.8% |
| 2024 | $0.00 | −$43.05M | — |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $6.53M | $1.53M | −$11.41M | −$45.01M | −688.8% |
| 2024 | $0.00 | $0.00 | $0.00 | −$43.05M | — |
Annual figures as reported, in the company's reporting currency. As of September 30, 2025.
Recent News
SRX Global Commits $2.5 Million to Launch Multi-Strategy Trading Platform in Partnership with 5T Trading, Powered by the EMJX Platform
YahooSRX Global and CERO 1236, a Wholly-Owned SPV, Enter into Definitive Agreement to Acquire CERo Therapeutics, an Innovative Cellular Immunotherapy Company Developing CER 1236 for Hematologic Malignancies
YahooSRX Global Inks Stock Purchase Agreement With Cero Therapeutics; To Acquire All Outstanding Stock Of Cero Therapeutics
BenzingaSRX Global Commits $1.5 Million to Launch Family of AI-Powered ETFs through its EMJX Platform, Partnering with Kupa AI Co-Founder Andy Kim
YahooSRX Global Announces $1.5M Commitment To Roll Out New Family Of Actively Managed ETFs
BenzingaSRX Global Provides Shareholders with Update on Liquidation of Two Portfolio Investments and Adds an Investment in Onconetix (Nasdaq: ONCO)
Yahoo
All 14 articles ↓Show fewer ↑
SRX Global CEO Kent Cunningham and President of EMJX Platform Eric Jackson to Present at Webull Corporate Connect Series Fintech Investment Webinar
YahooSRX Global Provides Shareholder Update on Portfolio Company, ARMR Sciences, a Clinical-Stage Biodefense Company
YahooSRX Global Acquires Senior Secured Debt in CERo Therapeutics Holdings, Inc., an Innovative Cellular Immunotherapy Company with Cancer Fighting Molecule for the Treatment of Hematologic Cancers
YahooSRX HealthSolutions Q3 2026 Earnings Call: Complete Transcript
BenzingaSRX HealthSolutions Q3 EPS $(0.36) Up From $(44.51) YoY, Sales $3.392M Up From $2.673M YoY
BenzingaSRX Global Acquires Stake In Vistagen Therapeutics; Deal Terms Were Undisclosed
BenzingaSRX Global’s Portfolio Company Smartkem To Merge With Ferrox Critical Minerals, Strengthening Its Critical Minerals Sourcing
BenzingaSRX Global Announces It Has Acquired Shares In Jersey Mike’s IPO; No Terms Disclosed
Benzinga
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.
Related Packaged Foods Stocks
The Kraft Heinz Company
$27.87B
GISGeneral Mills, Inc.
$17.41B
SAP.TOSaputo Inc.
CA$16.14B
SJMThe J. M. Smucker Company
$13.65B
JBSJBS N.V.
$13.35B
MKCMcCormick & Company, Incorporated
$12.46B
Popular Consumer Defensive Stocks
Walmart Inc.
$937.46B
COSTCostco Wholesale Corporation
$442.38B
KOThe Coca-Cola Company
$398.76B
PGThe Procter & Gamble Company
$364.29B
PMPhilip Morris International Inc.
$307.76B